Maternal smoking during pregnancy and offspring type 1 diabetes mellitus risk: accounting for HLA haplotype

2015 ◽  
Vol 30 (3) ◽  
pp. 231-238 ◽  
Author(s):  
Kristina Mattsson ◽  
Ida Jönsson ◽  
Ebba Malmqvist ◽  
Helena Elding Larsson ◽  
Lars Rylander
2020 ◽  
Vol 17 (1) ◽  
pp. 37-54
Author(s):  
Tatyana Chalakova ◽  
Yoto Yotov ◽  
Kaloyan Tzotchev ◽  
Sonya Galcheva ◽  
Boyan Balev ◽  
...  

: Type 1 diabetes mellitus (T1DM) is a chronic disease that starts early in life and often leads to micro- and macrovascular complications. The incidence of the disease is lower than that of type 2 DM and varies in different countries and ethnic groups, and the etiological and pathogenetic factors are different from T2DM. The aim of this overview is to investigate the effect of T1DM on all-cause mortality and CVD morbidity and mortality. During the last decades, the treatment of T1DM has improved the prognosis of the patients. Still, the mortality rates are higher than those of the age- and sex-matched general population. With the prolonged survival, the macrovascular complications and cardiovascular diseases (CVD) appear as major health problems in the management of patients with T1DM. The studies on the CVD morbidity and mortality in this disease group are sparse, but they reveal that T1DM is associated with at least 30% higher mortality. In comparison to healthy people, CVDs are more common in T1DM patients and they occur earlier in life. : Furthermore, they are a major cause for death and impaired quality of life in T1DM patients. The correlation between diabetic control and the duration of T1DM is not always present or is insignificant. Nevertheless, the early detection of the preclinical stages of the diseases and the risk factors for their development is important; similarly, the efforts to improve glycemic and metabolic control are of paramount importance.


2022 ◽  
Author(s):  
Yuxia Wei ◽  
Tomas Andersson ◽  
Jessica Edstorp ◽  
Josefin E. Lofvenborg ◽  
Mats Talback ◽  
...  

Objectives: Maternal smoking during pregnancy is associated with a reduced risk of type 1 diabetes (T1D) in the offspring. We investigated whether this association is consistent with a causal interpretation by accounting for familial (shared genetic and environmental) factors using family-based, quasi-experimental designs. Design: A nationwide, prospective cohort study and a nested case-control study (quasi-experiment) comparing children with T1D to their age-matched siblings (or cousins). Setting: Swedish national registers. Participants: We included 2,995,321 children born in Sweden between 1983 and 2014. Exposure: Information on maternal smoking during pregnancy was retrieved from the Swedish Medical Birth Register. Main outcome measures: Children were followed for a diagnosis of T1D until 2020 through the National Patient, Diabetes and Prescribed Drug Registers. Results: A total of 18,617 children developed T1D, with a median age at diagnosis of 9.4 years. The sibling and cousin comparison design included 14,284 and 7,988 of these children, respectively. Maternal smoking during pregnancy was associated with a 22% lower risk of offspring T1D in the full cohort (hazard ratio: 0.78, 95% confidence interval [CI]: 0.75 to 0.82) in the multivariable-adjusted model. The corresponding odds ratio was 0.78 (95% CI: 0.69 to 0.88) in the sibling and 0.72 (95% CI: 0.66 to 0.79) in the cousin comparison analysis. Conclusions: This nationwide, family-based study provides support for a protective effect of maternal smoking on offspring T1D. Mechanistic studies are needed to elucidate the underlying pathways behind this link.


Diabetologia ◽  
2020 ◽  
Vol 63 (6) ◽  
pp. 1162-1173 ◽  
Author(s):  
Mumtaz Begum ◽  
Rhiannon M. Pilkington ◽  
Catherine R. Chittleborough ◽  
John W. Lynch ◽  
Megan Penno ◽  
...  

Diabetologia ◽  
2013 ◽  
Vol 57 (3) ◽  
pp. 469-472 ◽  
Author(s):  
Aveni Haynes ◽  
Matthew N. Cooper ◽  
Carol Bower ◽  
Timothy W. Jones ◽  
Elizabeth A. Davis

Sign in / Sign up

Export Citation Format

Share Document